MarketPeel
Insider Trading Intelligence
Pricing
…
AB

Anthony Bergmann

CAPR
CHIEF FINANCIAL OFFICER · CAPRICOR THERAPEUTICS, INC. · CIK 0001593087
FILING MIX · LIFETIME57%/43%
BUYS
25
SELLS
19
TOTAL VALUE
$2.55M
COMPANIES
1
ACTIVE SINCE
Oct 2013
HOLDINGS NOW
11,223
AVG SELL PX
$30.73
TRADE KIND
SHOWING 44 / 44
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 7 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Anthony Bergmann, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+50.00%+1.73%+1.86%-0.14%-0.14%—
14d2+50.00%+6.02%+4.89%+1.13%+1.13%—
30d2+50.00%+3.69%+10.51%-0.04%-0.04%—
60d2+100.00%-13.25%+2.82%-25.08%-25.08%—
90d2(1 pending)+100.00%-13.03%+12.09%-25.12%-25.12%—
180d2(2 pending)——————
1y2(2 pending)——————
2y2(2 pending)——————
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CAPR · 11,223 shares · as of Jun 25, 2026
041,74583,490125,235166,9802014201520162017201820192020202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2013
2014
2014
2014
2014
2015
2015
2015
2015
2016
2016
2016
2016
2017
2017
2017
2017
2018
2018
2018
2018
2019
2019
2019
2019
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 25 buys / 19 sellsCOVERAGE · 51 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
CHIEF FINANCIAL OFFICER
24,100$30.38$732.2K11,223Jun 25, 2026Jun 29, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
CHIEF FINANCIAL OFFICER
24,100——91,980Jun 25, 2026Jun 29, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASE
CHIEF FINANCIAL OFFICER
24,100$3.18$76.6K35,323Jun 25, 2026Jun 29, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASE
CHIEF FINANCIAL OFFICER
400$3.18$1.3K11,623Jun 24, 2026Jun 24, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
CHIEF FINANCIAL OFFICER
400$30.00$12.0K11,223Jun 24, 2026Jun 24, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
CHIEF FINANCIAL OFFICER
400——116,080Jun 24, 2026Jun 24, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASE
CHIEF FINANCIAL OFFICER
500$3.18$1.6K11,723Jun 22, 2026Jun 24, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
CHIEF FINANCIAL OFFICER
500$30.00$15.0K11,223Jun 22, 2026Jun 24, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
CHIEF FINANCIAL OFFICER
500——116,480Jun 22, 2026Jun 24, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
CHIEF FINANCIAL OFFICER
3,000——0May 18, 2026May 19, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASE
CHIEF FINANCIAL OFFICER
3,000$1.39$4.2K11,223May 18, 2026May 19, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASE
CHIEF FINANCIAL OFFICER
25,000$3.18$79.5K33,223May 1, 2026May 4, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
CHIEF FINANCIAL OFFICER
25,000——116,980May 1, 2026May 4, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
25,000$31.70$792.5K8,223May 1, 2026May 4, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
25,000$30.13$753.2K8,223Mar 31, 2026Apr 1, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
CHIEF FINANCIAL OFFICER
25,000——141,980Mar 31, 2026Apr 1, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASE
CHIEF FINANCIAL OFFICER
25,000$3.18$79.5K33,223Mar 31, 2026Apr 1, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,500——2,500Jan 5, 2026Jan 7, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
25,000——25,000Jan 5, 2026Jan 7, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
CHIEF FINANCIAL OFFICER
2,500——0Mar 3, 2025Mar 4, 2025 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASE
CHIEF FINANCIAL OFFICER
2,500$1.39$3.5K8,223Mar 3, 2025Mar 4, 2025 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
6,170——6,170Jan 2, 2025Jan 6, 2025 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
75,000——75,000Jan 2, 2025Jan 6, 2025 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,342——5,723Jan 2, 2025Jan 6, 2025 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
9,692——9,692Jan 2, 2024Jan 4, 2024 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
85,000——85,000Jan 2, 2024Jan 4, 2024 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASE
CHIEF FINANCIAL OFFICER
2,178$1.39$3.0K2,381Oct 23, 2023Oct 24, 2023 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
85,000——85,000Jan 3, 2023Jan 5, 2023 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
166,980——166,980Jan 3, 2022Jan 4, 2022 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
95,693——95,693Jan 4, 2021Jan 6, 2021 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
120,003——120,003Jun 5, 2020Jun 9, 2020 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,178——2,178Feb 12, 2020Feb 14, 2020 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
CHIEF FINANCIAL OFFICER
2,178——0Feb 12, 2020Feb 14, 2020 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
CHIEF FINANCIAL OFFICER
3,000——0Feb 12, 2020Feb 14, 2020 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,000——3,000Feb 12, 2020Feb 14, 2020 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,500——2,500Feb 12, 2020Feb 14, 2020 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
CHIEF FINANCIAL OFFICER
5,000——0Feb 12, 2020Feb 14, 2020 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
CHIEF FINANCIAL OFFICER
14,000——0Feb 12, 2020Feb 14, 2020 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
14,000——14,000Feb 12, 2020Feb 14, 2020 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,500——3,500Feb 12, 2020Feb 14, 2020 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,000——5,000Feb 12, 2020Feb 14, 2020 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
CHIEF FINANCIAL OFFICER
2,500——0Feb 12, 2020Feb 14, 2020 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
CHIEF FINANCIAL OFFICER
3,500——0Feb 12, 2020Feb 14, 2020 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
CHIEF FINANCIAL OFFICER
2,178——0Oct 23, 2013Oct 24, 2023 ↗View →
Other insiders · CAPR
Loading peer insiders…
About this filer
CIK 0001593087
ROLE
CHIEF FINANCIAL OFFICER
PRIMARY
CAPR
COMPANIES
1
ACTIVE SINCE
Oct 2013
MARKETPEEL · /INSIDER/0001593087DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback